Moreover, in humans, Wieckowska et al. reported that IL-6 expression is markedly higher in the livers of patients with nonalcoholic steatohepatitis (NASH) than in patients with simple steatosis or normal biopsies [26]. Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.